Coherus BioSciences (NasdaqGM:CHRS) FY Conference Transcript

Coherus BioSciences (NasdaqGM:CHRS) FY Conference September 10, 2025 11:00 AM ET Company ParticipantsDenny Lanfear - President and CEOTheresa LaVallee - Chief Scientific and Development OfficerConference Call ParticipantsDouglas Tsao - Senior AnalystDouglas TsaoOkay, we'll get started. Thank you, everybody. I'm Doug Tsao, Senior Analyst at HC Wainwright. We are thrilled to have Coherus Oncology with us next, represented by the company's CEO and founder, Denny Lanfear, and Theresa LaVallee, who's the Chief S ...